XV Konferencja Naukowa Polskiego Towarzystwa Hepatologicznego
News
Current issue
Archival Issues
Search
Newsletter
Manuscript Submission
 » 
Journal Abstract
 
Lamivudine – still actual therapeutic option for protection of HBV infection reactivation and vertical transmission
Waldemar Halota, Małgorzata Pawłowska
Medical Science Review - Hepatologia 2010; 10 58-61
aaICID: 911683
Article type: Review article
IC™ Value: 3.34
Abstract provided by Publisher
 
Immunosuppressant therapy induced risk of HBV reactivation among selected group of patients. It concerns especially patients with anti-HBc serum presence. Among them occult B hepatitis are very frequent. Risk of reactivation needs chemoprophylaxis. Lamivudine is the first line therapy, because of limited period of treatment. Antiviral therapy with Lamivudine during the third trimester of pregnancy in high – risk women with HBV infection reduces viral load in the mother and may decrease the risk of perinatal transmission.

ICID 911683
 
FULL TEXT 198 KB


Related articles
  • in IndexCopernicus™
         reaktywacja [0 related records]
         transmisja wertykalna [0 related records]


  •  

    Copyright © Medical Science Review - Hepatologia  2017
    Page created by Index Copernicus Ltd. All Rights reserved.